Integra LifeSciences cut its 2026 revenue outlook — a long-dated guide, which is the part that stings, because it tells you management doesn't see the current growth slope holding. Valuation debates f

Integra LifeSciences cut its 2026 revenue outlook, prompting fair value concerns.